Technical data
Indication
|
---|
Orsiro Mission is indicated for improving coronary luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease, stable angina, unstable angina, non-ST-elevation myocardial infarction or documented silent ischemia due to atherosclerotic lesions in the native coronary arteries with a reference vessel diameter of 2.25 mm to 4.0 mm and a lesion length of ≤ 36 mm. |
STENT | |
---|---|
Stent Material | Cobalt chromium, L-605 |
Strut thickness | ø 2.25 - 3.0 mm: 60 μma (0.0024”); ø 3.50 - 4.0 mm: 80 μm (0.0031”) |
Passive coating | proBIOTM (Amorphous Silicon Carbide) |
Active coating | BIOlute® bioabsorbable drug matrix consisting of sirolimus and ploymer poly-l-lactide (PLLA) |
Drug dose | 1.4 μg/mm2 |
Delivery system | |
---|---|
Catheter type | Fast-exchange |
Recommended guide catheter | 5 F (min. I.D.b ≥ 0.056“) |
Guide wire diameter | 0.014” (0.36 mm) |
Usable catheter length | 140 cm |
Balloon material | Semi crystalline polymer |
Coating (Distal shaft) | Hydrophilic |
Coating (Proximal shaft) | Hydrophobic |
Marker bands | Two platinum-iridium markers |
Proximal shaft diameter | 2.0 F |
Distal shaft diameter | 2.7 F: Ø 2.25 - 3.0 mm; 2.9 F: Ø 3.5 - 4.0 mm |
Nominal pressure (NP) | 10 atm |
Rated burst pressure (RBP) | 16 atm |
Ordering Information
STENT Ø (MM) | Stent length (mm) | ||||||||
---|---|---|---|---|---|---|---|---|---|
9 | 13 | 15 | 18 | 22 | 26 | 30 | 35 | 40 | |
2.25 | 453925 | 453931 | 453937 | 453943 | 453949 | 453955 | 453961 | ||
2.50 | 453926 | 453932 | 453938 | 453944 | 453950 | 453956 | 453962 | 453968 | 453974 |
2.75 | 453927 | 453933 | 453939 | 453945 | 453951 | 453957 | 453963 | 453969 | 453975 |
3.00 | 453928 | 453934 | 453940 | 453946 | 453952 | 453958 | 453964 | 453970 | 453976 |
3.50 | 453929 | 453935 | 453941 | 453947 | 453953 | 453959 | 453965 | 453971 | 453977 |
4.00 | 453930 | 453936 | 453942 | 453948 | 453954 | 453960 | 453966 | 453972 | 453978 |